artenimol has been researched along with Angiogenesis, Pathologic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Chen, X; Feng, R; Li, N; Luo, Q; Yang, S; Zhang, D; Zhang, S | 1 |
| Chen, SS; Hu, W; Lou, XE; Wang, Z; Zhang, JL; Zhou, HJ | 1 |
| Ba, Q; Chen, PZ; Chen, T; Chu, RA; Duan, J; Li, JQ; Li, XG; Tian, JQ; Wang, H; Wang, ZL; Wu, SJ; Xiang, L | 1 |
| Chen, L; Feng, C; Liang, G; Lin, R; Wang, L; Zhang, Z; Zhou, Y; Zou, P | 1 |
| Fei, J; Li, J; Shen, R; Wang, Q; Ye, D | 1 |
| Chen, H; Kong, R; Li, Y; Pan, S; Sun, B; Wang, Y; Xue, D | 1 |
| Bai, XW; Chen, H; Cheng, ZX; Gao, Y; Jiang, HC; Kong, R; Pan, SH; Sun, B; Wang, SJ; Xue, DB; Zhou, HX | 1 |
| Chen, HH; Fang, X; Zhou, HJ | 1 |
| Li, J; Zhou, HJ | 1 |
9 other study(ies) available for artenimol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Effects and Mechanisms of Anlotinib and Dihydroartemisinin Combination Therapy in Ameliorating Malignant Biological Behavior of Gastric Cancer Cells.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Artemisinins; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Indoles; Ki-67 Antigen; Neoplasm Invasiveness; Neovascularization, Pathologic; Proto-Oncogene Proteins c-bcl-2; Quinolines; Stomach Neoplasms; Vascular Endothelial Growth Factor A | 2021 |
DHA regulates angiogenesis and improves the efficiency of CDDP for the treatment of lung carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Artemisinins; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Neovascularization, Pathologic; Time Factors; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2013 |
Dihydroartemisinin promotes angiogenesis during the early embryonic development of zebrafish.
Topics: Animals; Animals, Genetically Modified; Artemisia; Artemisinins; Embryo, Nonmammalian; Embryonic Development; Neovascularization, Pathologic; Zebrafish | 2013 |
Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells.
Topics: Angiogenesis Inhibitors; Angiogenic Proteins; Apoptosis; Artemisinins; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Forkhead Box Protein M1; Head and Neck Neoplasms; Human Umbilical Vein Endothelial Cells; Humans; Neovascularization, Pathologic; Neovascularization, Physiologic; RNA Interference; Signal Transduction; Time Factors; Transfection | 2016 |
Combination of onconase and dihydroartemisinin synergistically suppresses growth and angiogenesis of non-small-cell lung carcinoma and malignant mesothelioma.
Topics: A549 Cells; Animals; Antimalarials; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Artemisinins; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Immunohistochemistry; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Ribonucleases; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2016 |
Dihydroartemisinin suppresses pancreatic cancer cells via a microRNA-mRNA regulatory network.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Artemisinins; Cell Line, Tumor; Cell Proliferation; Female; Gene Regulatory Networks; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; RNA, Messenger; Transfection | 2016 |
Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway.
Topics: Angiogenesis Inhibitors; Animals; Artemisinins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Endothelial Cells; Humans; Male; Mice; Neovascularization, Pathologic; NF-kappa B; Pancreatic Neoplasms | 2011 |
Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro.
Topics: Angiogenesis Inhibitors; Artemisinins; Artesunate; Cell Culture Techniques; Cell Line, Tumor; Dose-Response Relationship, Drug; Endothelium, Vascular; Growth Inhibitors; Humans; Neovascularization, Pathologic; Sesquiterpenes; Umbilical Veins | 2003 |
[Dihydroartemisinin inhibits the expression of vascular endothelial growth factor in K562 cells].
Topics: Animals; Antineoplastic Agents, Phytogenic; Artemisinins; Cell Proliferation; Chickens; Chorioallantoic Membrane; Dose-Response Relationship, Drug; Down-Regulation; Humans; K562 Cells; Neovascularization, Pathologic; RNA, Messenger; Sesquiterpenes; Vascular Endothelial Growth Factor A | 2005 |